Sitemap

VBC News

• Valent BioSciences Announces Osage Facility Environmental Initiatives - 12 January 2022
• Valent BioSciences and Kansas State University Sign Collaborative Agreement for Soil Health Research Initiative with Dr. Charles W. Rice - 23 September 2021
• Valent BioSciences Announces U.S. EPA Registration of Accede^TM Plant Growth Regulator for Effective Thinning of Stone Fruit and Apples - 1 July 2021
• Valent BioSciences and Valent U.S.A. Collaborate with Halo on Open Innovation Initiative Seeking New Technologies and Solutions - 23 June 2021
• Valent BioSciences Introduces MetaLarv^® XRP for Long-Lasting, Consistent Control in Catch Basin Mosquito Habitats - 5 May 2021
• Valent BioSciences Celebrates 50th Anniversary of DiPel^® Biological Insecticide as the Industry’s Most Effective Lepidopteran Control Product - 5 March 2021
• Valent BioSciences Announces New Educational Initiatives Supporting World Soil Day, Healthy Soils, and Sustainable Crop Production - 3 December 2020
• Valent BioSciences Boosts Capabilities with New Biorational Research Unit at Sumitomo Chemical Health & Crop Sciences Research Laboratory - 19 November 2020
• SATT Paris-Saclay and Valent BioSciences Sign Joint Agreement to Develop Breakthrough Sustainable Biopesticide Technologies - 27 October 2020
• Valent BioSciences Announces Creation of New Chief Commercial Officer Position and Other Organizational and Reporting Changes to Drive Growth - 23 September 2020
• Valent BioSciences Moves into New Global Biorational Headquarters - 17 September 2020
• Valent BioSciences, ADAPCO Form Strategic Partnership in Public Health - 29 August 2018
• Valent BioSciences Unveils New Biorational Research Center - 25 July 2018
• Valent BioSciences is Named Winner of Chicago Innovation Award for VectoBac® WDG and WALS™ Application Platform - 31 October 2017
• Valent BioSciences Corporation Reaches Distribution Deal for Actinovate® Brands with The BioAg Alliance - 19 January 2016
• Valent BioSciences Corporation Acquires Mycorrhizal Applications, Inc. - 4 March 2015
• U.S. EPA Approves New VectoPrime™ Biological Larvicide for Single-brood Floodwater Mosquito Larvae Programs - 24 February 2015
• Valent BioSciences Corporation Unveils its State-of-the-Art Biorational Manufacturing Facility in Osage, Iowa - 27 June 2014
• Valent BioSciences Corporation Earns ISO 9001:2008 Re-certification Following a System-Wide Audit - 11 December 2013
• Richards Joins Valent BioSciences Corporation as Plant Manager for new Osage Manufacturing Facility - 22 October 2013
• Ted Melnik Joins Valent BioSciences as Executive Vice President & Chief Operating Officer - 19 August 2013
• Valent BioSciences’ $150M New Manufacturing Facility On Track for Completion in Iowa - 4 April 2013
• MetaLarv™ S-PT Launch Marks Innovative Biorational Mosquito Growth Regulator for Use in Public Health - 17 April 2012
• Groundbreaking Ceremony for Valent BioSciences Marks Growth of Biorational Product Segment in Agriculture - 16 March 2012
• Valent BioSciences Files Patent Applications Claiming Benefits of Abscisic Acid in Animal Feed - 16 February 2012
• Osage, IA, and Valent BioSciences gear up for construction of landmark manufacturing facility - 18 January 2012
• EPA Approves New MetaLarv™ S-PT Mosquito Growth Regulator Featuring Advanced Triple-Release Formulation Technology - 25 October 2011
• EPA Approves New MetaLarv™ S-PT Mosquito Growth Regulator Featuring Advanced Triple-Release Formulation Technology - 25 October 2011
• Valent BioSciences Corporation Achieves ISO 9001:2008 Registration for U.S. Operations - 20 July 2010
• Valent BioSciences Corporation Announces Plan to Construct Fermentation Manufacturing Facility in Osage, Iowa - 25 April 2010
• Novel Microbial Insecticide Product Makes Short List for Two Major Innovation Awards - 9 October 2009
• New VectoMax Biological Larvicide for Mosquito Control - 26 March 2009

• MetaLarv®
• VectoBac®
• VectoMax®
• Bactimos®
• VectoLex®
• Teknar®
• VectoPrime®

• MetaLarv®
• VectoBac®
• VectoMax®
• Bactimos®
• VectoLex®
• Teknar®
• VectoPrime®